Structure

Physi-Chem Properties

Molecular Weight:  538.21
Volume:  519.61
LogP:  -0.394
LogD:  0.342
LogS:  -2.171
# Rotatable Bonds:  12
TPSA:  187.76
# H-Bond Aceptor:  12
# H-Bond Donor:  7
# Rings:  3
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.187
Synthetic Accessibility Score:  4.26
Fsp3:  0.462
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.952
MDCK Permeability:  2.0136772945988923e-05
Pgp-inhibitor:  0.004
Pgp-substrate:  0.943
Human Intestinal Absorption (HIA):  0.879
20% Bioavailability (F20%):  0.181
30% Bioavailability (F30%):  0.991

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.314
Plasma Protein Binding (PPB):  65.68988800048828%
Volume Distribution (VD):  0.361
Pgp-substrate:  19.675395965576172%

ADMET: Metabolism

CYP1A2-inhibitor:  0.024
CYP1A2-substrate:  0.111
CYP2C19-inhibitor:  0.014
CYP2C19-substrate:  0.638
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.621
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.252
CYP3A4-inhibitor:  0.021
CYP3A4-substrate:  0.126

ADMET: Excretion

Clearance (CL):  2.656
Half-life (T1/2):  0.842

ADMET: Toxicity

hERG Blockers:  0.288
Human Hepatotoxicity (H-HT):  0.091
Drug-inuced Liver Injury (DILI):  0.228
AMES Toxicity:  0.211
Rat Oral Acute Toxicity:  0.026
Maximum Recommended Daily Dose:  0.003
Skin Sensitization:  0.16
Carcinogencity:  0.253
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.006

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470413

Natural Product ID:  NPC470413
Common Name*:   2-((E)-3-{4-[2-Hydroxy-2-(4-Hydroxy-3-Methoxy-Phenyl)-1-Hydroxymethyl-Ethoxy]-3-Methoxy-Phenyl}-Allyloxy)-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
IUPAC Name:   (2R,3R,4S,5S,6R)-2-[(E)-3-[4-[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy-3-methoxyphenyl]prop-2-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
Synonyms:  
Standard InCHIKey:  KMRNHQMTDWXUBS-DTFCWUHSSA-N
Standard InCHI:  InChI=1S/C26H34O12/c1-34-18-11-15(6-7-16(18)29)22(30)20(12-27)37-17-8-5-14(10-19(17)35-2)4-3-9-36-26-25(33)24(32)23(31)21(13-28)38-26/h3-8,10-11,20-33H,9,12-13H2,1-2H3/b4-3+/t20?,21-,22?,23-,24+,25-,26-/m1/s1
SMILES:  COC1=C(C=CC(=C1)C=CCOC2C(C(C(C(O2)CO)O)O)O)OC(CO)C(C3=CC(=C(C=C3)O)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2029018
PubChem CID:   11478224
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds
      • [CHEMONTID:0001511] Lignan glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota roots Miyazaki prefecture, Japan n.a. PMID[9873511]
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO3509 Angelica furcijuga Species Apiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT29 Organism Rattus norvegicus Rattus norvegicus IC50 > 100000.0 nM PMID[547025]
NPT29 Organism Rattus norvegicus Rattus norvegicus Inhibition = -0.2 % PMID[547025]
NPT32 Organism Mus musculus Mus musculus IC50 > 100000.0 nM PMID[547025]
NPT32 Organism Mus musculus Mus musculus Inhibition = -26.0 % PMID[547025]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470413 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC138738
0.9771 High Similarity NPC177035
0.9771 High Similarity NPC52277
0.9771 High Similarity NPC199459
0.9769 High Similarity NPC187194
0.9701 High Similarity NPC469559
0.9699 High Similarity NPC106944
0.963 High Similarity NPC46092
0.963 High Similarity NPC185307
0.963 High Similarity NPC470950
0.9618 High Similarity NPC35731
0.9618 High Similarity NPC476411
0.9559 High Similarity NPC129417
0.9559 High Similarity NPC283995
0.9559 High Similarity NPC470235
0.9556 High Similarity NPC476356
0.9556 High Similarity NPC189115
0.9538 High Similarity NPC65942
0.9538 High Similarity NPC248307
0.9489 High Similarity NPC279298
0.9489 High Similarity NPC22150
0.9489 High Similarity NPC18979
0.9489 High Similarity NPC475096
0.9489 High Similarity NPC38041
0.9481 High Similarity NPC472711
0.9481 High Similarity NPC469661
0.9478 High Similarity NPC98777
0.9478 High Similarity NPC212770
0.9462 High Similarity NPC80600
0.9462 High Similarity NPC472024
0.942 High Similarity NPC112861
0.9416 High Similarity NPC473045
0.9416 High Similarity NPC25292
0.9412 High Similarity NPC475084
0.9403 High Similarity NPC59324
0.9403 High Similarity NPC304152
0.9403 High Similarity NPC65530
0.9389 High Similarity NPC9912
0.9385 High Similarity NPC307110
0.9385 High Similarity NPC248355
0.9385 High Similarity NPC5851
0.9385 High Similarity NPC166040
0.9385 High Similarity NPC270849
0.9385 High Similarity NPC86030
0.9385 High Similarity NPC26653
0.9353 High Similarity NPC224674
0.9353 High Similarity NPC114505
0.9353 High Similarity NPC227902
0.9353 High Similarity NPC193473
0.9353 High Similarity NPC275284
0.9353 High Similarity NPC39657
0.9353 High Similarity NPC31325
0.9353 High Similarity NPC15956
0.9353 High Similarity NPC213074
0.9343 High Similarity NPC113680
0.9343 High Similarity NPC477898
0.9343 High Similarity NPC278961
0.9343 High Similarity NPC473044
0.9343 High Similarity NPC478239
0.9328 High Similarity NPC242028
0.9328 High Similarity NPC203230
0.9323 High Similarity NPC470881
0.9308 High Similarity NPC302378
0.9308 High Similarity NPC72529
0.9281 High Similarity NPC190714
0.9281 High Similarity NPC99515
0.9281 High Similarity NPC125755
0.9275 High Similarity NPC84181
0.927 High Similarity NPC246947
0.927 High Similarity NPC48309
0.927 High Similarity NPC140502
0.927 High Similarity NPC60249
0.927 High Similarity NPC5262
0.927 High Similarity NPC157816
0.927 High Similarity NPC472714
0.9248 High Similarity NPC25821
0.9248 High Similarity NPC6836
0.9231 High Similarity NPC292056
0.9231 High Similarity NPC118787
0.9231 High Similarity NPC319625
0.9231 High Similarity NPC163332
0.9231 High Similarity NPC147821
0.9231 High Similarity NPC41706
0.9231 High Similarity NPC111247
0.9231 High Similarity NPC183181
0.922 High Similarity NPC286235
0.922 High Similarity NPC106138
0.922 High Similarity NPC44452
0.922 High Similarity NPC51328
0.922 High Similarity NPC55158
0.9209 High Similarity NPC286245
0.9209 High Similarity NPC34587
0.9209 High Similarity NPC277867
0.9209 High Similarity NPC43508
0.9209 High Similarity NPC476382
0.9209 High Similarity NPC100998
0.9209 High Similarity NPC272619
0.9209 High Similarity NPC161700
0.9209 High Similarity NPC469586
0.9209 High Similarity NPC252292
0.9209 High Similarity NPC34927
0.9209 High Similarity NPC476301
0.9203 High Similarity NPC252169
0.9197 High Similarity NPC186406
0.9197 High Similarity NPC76871
0.9185 High Similarity NPC164857
0.9179 High Similarity NPC13745
0.9179 High Similarity NPC251981
0.9179 High Similarity NPC48863
0.9179 High Similarity NPC87696
0.9179 High Similarity NPC107478
0.9179 High Similarity NPC170694
0.9173 High Similarity NPC252833
0.9173 High Similarity NPC254275
0.916 High Similarity NPC245826
0.916 High Similarity NPC252307
0.916 High Similarity NPC474178
0.9155 High Similarity NPC98624
0.9155 High Similarity NPC475224
0.9154 High Similarity NPC58607
0.9154 High Similarity NPC178284
0.9154 High Similarity NPC191037
0.9149 High Similarity NPC175976
0.9149 High Similarity NPC130449
0.9149 High Similarity NPC116229
0.9149 High Similarity NPC248132
0.9143 High Similarity NPC199928
0.9143 High Similarity NPC476865
0.9137 High Similarity NPC472713
0.9137 High Similarity NPC217635
0.9137 High Similarity NPC253015
0.9137 High Similarity NPC473046
0.9137 High Similarity NPC232228
0.9137 High Similarity NPC472712
0.9137 High Similarity NPC168579
0.9137 High Similarity NPC471065
0.9137 High Similarity NPC79429
0.9137 High Similarity NPC76176
0.9137 High Similarity NPC187774
0.9137 High Similarity NPC469313
0.9137 High Similarity NPC471667
0.9137 High Similarity NPC138227
0.9137 High Similarity NPC471063
0.9137 High Similarity NPC118385
0.913 High Similarity NPC477794
0.913 High Similarity NPC477799
0.913 High Similarity NPC477800
0.9118 High Similarity NPC477798
0.9118 High Similarity NPC477797
0.9111 High Similarity NPC101624
0.9111 High Similarity NPC184938
0.9111 High Similarity NPC470236
0.9104 High Similarity NPC132895
0.9104 High Similarity NPC115022
0.9104 High Similarity NPC69513
0.9104 High Similarity NPC294166
0.9104 High Similarity NPC215833
0.9104 High Similarity NPC49074
0.9098 High Similarity NPC166168
0.9084 High Similarity NPC79715
0.9084 High Similarity NPC108659
0.9084 High Similarity NPC264900
0.9084 High Similarity NPC231607
0.9078 High Similarity NPC473480
0.9078 High Similarity NPC15538
0.9078 High Similarity NPC232992
0.9077 High Similarity NPC194519
0.9071 High Similarity NPC476866
0.9071 High Similarity NPC476869
0.9071 High Similarity NPC476864
0.9071 High Similarity NPC476868
0.9065 High Similarity NPC37793
0.9051 High Similarity NPC100389
0.9051 High Similarity NPC156376
0.9044 High Similarity NPC138350
0.9044 High Similarity NPC165482
0.9044 High Similarity NPC172818
0.9044 High Similarity NPC3293
0.9044 High Similarity NPC197723
0.9044 High Similarity NPC25695
0.9044 High Similarity NPC40664
0.903 High Similarity NPC85799
0.903 High Similarity NPC184447
0.903 High Similarity NPC160991
0.903 High Similarity NPC165686
0.903 High Similarity NPC35932
0.903 High Similarity NPC303422
0.903 High Similarity NPC26080
0.903 High Similarity NPC162093
0.903 High Similarity NPC470270
0.903 High Similarity NPC16208
0.903 High Similarity NPC7903
0.903 High Similarity NPC299144
0.9021 High Similarity NPC472710
0.9021 High Similarity NPC472709
0.9014 High Similarity NPC280945
0.9008 High Similarity NPC94179
0.9007 High Similarity NPC276753
0.9007 High Similarity NPC205796
0.9 High Similarity NPC110063

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470413 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8777 High Similarity NPD7266 Discontinued
0.8667 High Similarity NPD3027 Phase 3
0.8613 High Similarity NPD1612 Clinical (unspecified phase)
0.8613 High Similarity NPD1613 Approved
0.8435 Intermediate Similarity NPD1653 Approved
0.8392 Intermediate Similarity NPD6674 Discontinued
0.8346 Intermediate Similarity NPD1091 Approved
0.8321 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8248 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.8228 Intermediate Similarity NPD7054 Approved
0.8176 Intermediate Similarity NPD7074 Phase 3
0.8176 Intermediate Similarity NPD7472 Approved
0.8074 Intermediate Similarity NPD3705 Approved
0.7985 Intermediate Similarity NPD1357 Approved
0.7963 Intermediate Similarity NPD7251 Discontinued
0.7937 Intermediate Similarity NPD7228 Approved
0.7937 Intermediate Similarity NPD3818 Discontinued
0.7923 Intermediate Similarity NPD228 Approved
0.7914 Intermediate Similarity NPD7808 Phase 3
0.7901 Intermediate Similarity NPD6797 Phase 2
0.7857 Intermediate Similarity NPD2861 Phase 2
0.7852 Intermediate Similarity NPD5058 Phase 3
0.7834 Intermediate Similarity NPD6234 Discontinued
0.7805 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD7685 Pre-registration
0.7742 Intermediate Similarity NPD37 Approved
0.7742 Intermediate Similarity NPD1934 Approved
0.7727 Intermediate Similarity NPD7843 Approved
0.7708 Intermediate Similarity NPD1558 Phase 1
0.7707 Intermediate Similarity NPD4966 Approved
0.7707 Intermediate Similarity NPD4967 Phase 2
0.7707 Intermediate Similarity NPD4965 Approved
0.7698 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD2977 Approved
0.7692 Intermediate Similarity NPD2978 Approved
0.7692 Intermediate Similarity NPD8455 Phase 2
0.7687 Intermediate Similarity NPD7157 Approved
0.7682 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7676 Intermediate Similarity NPD4908 Phase 1
0.7671 Intermediate Similarity NPD4538 Approved
0.7671 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7671 Intermediate Similarity NPD4536 Approved
0.7669 Intermediate Similarity NPD5283 Phase 1
0.7658 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD7199 Phase 2
0.7595 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD6166 Phase 2
0.7593 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD3620 Phase 2
0.7586 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD2982 Phase 2
0.7571 Intermediate Similarity NPD2983 Phase 2
0.7569 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7557 Intermediate Similarity NPD2684 Approved
0.7554 Intermediate Similarity NPD1610 Phase 2
0.7518 Intermediate Similarity NPD1548 Phase 1
0.75 Intermediate Similarity NPD2981 Phase 2
0.75 Intermediate Similarity NPD5588 Approved
0.75 Intermediate Similarity NPD5960 Phase 3
0.7483 Intermediate Similarity NPD3018 Phase 2
0.7468 Intermediate Similarity NPD2801 Approved
0.7466 Intermediate Similarity NPD4060 Phase 1
0.7455 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7434 Intermediate Similarity NPD6190 Approved
0.7432 Intermediate Similarity NPD7097 Phase 1
0.7426 Intermediate Similarity NPD6671 Approved
0.7425 Intermediate Similarity NPD6559 Discontinued
0.7425 Intermediate Similarity NPD7240 Approved
0.7423 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7417 Intermediate Similarity NPD3060 Approved
0.74 Intermediate Similarity NPD1375 Discontinued
0.7397 Intermediate Similarity NPD6233 Phase 2
0.7394 Intermediate Similarity NPD8651 Approved
0.7379 Intermediate Similarity NPD7095 Approved
0.7368 Intermediate Similarity NPD3022 Approved
0.7368 Intermediate Similarity NPD3021 Approved
0.7353 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7348 Intermediate Similarity NPD290 Approved
0.7329 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD3817 Phase 2
0.731 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD4237 Approved
0.7303 Intermediate Similarity NPD4236 Phase 3
0.7303 Intermediate Similarity NPD4162 Approved
0.7297 Intermediate Similarity NPD5735 Approved
0.7292 Intermediate Similarity NPD6584 Phase 3
0.729 Intermediate Similarity NPD4123 Phase 3
0.7286 Intermediate Similarity NPD5125 Phase 3
0.7286 Intermediate Similarity NPD5126 Approved
0.7286 Intermediate Similarity NPD5846 Approved
0.7286 Intermediate Similarity NPD6516 Phase 2
0.7285 Intermediate Similarity NPD2029 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD968 Approved
0.7267 Intermediate Similarity NPD4108 Discontinued
0.7267 Intermediate Similarity NPD3882 Suspended
0.7261 Intermediate Similarity NPD3687 Approved
0.7261 Intermediate Similarity NPD3686 Approved
0.726 Intermediate Similarity NPD4625 Phase 3
0.7255 Intermediate Similarity NPD4628 Phase 3
0.725 Intermediate Similarity NPD5773 Approved
0.725 Intermediate Similarity NPD5772 Approved
0.7248 Intermediate Similarity NPD6653 Approved
0.7231 Intermediate Similarity NPD291 Approved
0.7226 Intermediate Similarity NPD1511 Approved
0.7211 Intermediate Similarity NPD6798 Discontinued
0.7211 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7208 Intermediate Similarity NPD2677 Approved
0.7205 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD4749 Approved
0.7197 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7194 Intermediate Similarity NPD5536 Phase 2
0.719 Intermediate Similarity NPD5177 Phase 3
0.719 Intermediate Similarity NPD1652 Phase 2
0.7188 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD6355 Discontinued
0.7181 Intermediate Similarity NPD4340 Discontinued
0.7171 Intermediate Similarity NPD5762 Approved
0.7171 Intermediate Similarity NPD5763 Approved
0.717 Intermediate Similarity NPD4678 Approved
0.717 Intermediate Similarity NPD4675 Approved
0.7162 Intermediate Similarity NPD1726 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD3787 Discontinued
0.7143 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6331 Phase 2
0.7143 Intermediate Similarity NPD4110 Phase 3
0.7143 Intermediate Similarity NPD5844 Phase 1
0.7143 Intermediate Similarity NPD4535 Phase 3
0.7135 Intermediate Similarity NPD8312 Approved
0.7135 Intermediate Similarity NPD8313 Approved
0.7134 Intermediate Similarity NPD1512 Approved
0.7133 Intermediate Similarity NPD2231 Phase 2
0.7133 Intermediate Similarity NPD2235 Phase 2
0.7117 Intermediate Similarity NPD7075 Discontinued
0.7115 Intermediate Similarity NPD1774 Approved
0.7111 Intermediate Similarity NPD556 Approved
0.7107 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7095 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD8127 Discontinued
0.7083 Intermediate Similarity NPD6582 Phase 2
0.7083 Intermediate Similarity NPD3685 Discontinued
0.7083 Intermediate Similarity NPD6583 Phase 3
0.708 Intermediate Similarity NPD5535 Approved
0.7069 Intermediate Similarity NPD6842 Approved
0.7069 Intermediate Similarity NPD6841 Approved
0.7069 Intermediate Similarity NPD6843 Phase 3
0.7063 Intermediate Similarity NPD4380 Phase 2
0.7051 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD2674 Phase 3
0.7047 Intermediate Similarity NPD4062 Phase 3
0.7039 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD7033 Discontinued
0.7037 Intermediate Similarity NPD1465 Phase 2
0.7033 Intermediate Similarity NPD7680 Approved
0.7032 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD7526 Approved
0.7025 Intermediate Similarity NPD52 Approved
0.7025 Intermediate Similarity NPD7527 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD5261 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4140 Approved
0.7 Intermediate Similarity NPD5837 Clinical (unspecified phase)
0.6994 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6993 Remote Similarity NPD3496 Discontinued
0.6987 Remote Similarity NPD5307 Clinical (unspecified phase)
0.6987 Remote Similarity NPD5241 Discontinued
0.6982 Remote Similarity NPD3751 Discontinued
0.6981 Remote Similarity NPD2122 Discontinued
0.698 Remote Similarity NPD5718 Phase 2
0.6974 Remote Similarity NPD4978 Clinical (unspecified phase)
0.6971 Remote Similarity NPD7906 Approved
0.6966 Remote Similarity NPD5327 Phase 3
0.6966 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6964 Remote Similarity NPD27 Approved
0.6964 Remote Similarity NPD2489 Approved
0.6962 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6962 Remote Similarity NPD3536 Discontinued
0.6962 Remote Similarity NPD7447 Phase 1
0.6954 Remote Similarity NPD5124 Phase 1
0.6954 Remote Similarity NPD1933 Approved
0.6954 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6948 Remote Similarity NPD3540 Phase 1
0.6946 Remote Similarity NPD6071 Discontinued
0.6944 Remote Similarity NPD422 Phase 1
0.6936 Remote Similarity NPD7312 Approved
0.6936 Remote Similarity NPD7313 Approved
0.6936 Remote Similarity NPD7311 Approved
0.6936 Remote Similarity NPD7310 Approved
0.6933 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6913 Remote Similarity NPD3179 Approved
0.6913 Remote Similarity NPD3180 Approved
0.6909 Remote Similarity NPD5604 Discontinued
0.6908 Remote Similarity NPD3054 Approved
0.6908 Remote Similarity NPD3052 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data